Search
28 results
-
Multiple Sclerosis multiple-sclerosis represents the most clinically established application
matched in: search_vector
-
Multiple Sclerosis [multiple-sclerosis](/diseases/multiple-sclerosis) involves focal [blood-brain-barrier
matched in: search_vector
-
sclerosis | Motor [neurons Disease] - multiple-sclerosis | adrenoleukodystrophy - Microtubule Dynamics | axonal
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis) ([Khalil et al., 2018](https://doi.org/10.1038/s41582-018-0058-z)).
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis) 3. **Infectious** — [creutzfeldt-jakob](/diseases/creutzfeldt-jakob), HIV-associated
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis)**: Serum GFAP peaks during relapses and correlates
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis), [autoimmune-encephalitis](/diseases/autoimmune-encephalitis), and CNS lymphoma. [@stern1985
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis) ([Mathys et al., 2019](https://doi.org/10.1038/s41586-019-1195-2)).
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis). In these conditions, NRF2 activity declines with
matched in: search_vector
-
Multiple Sclerosis In [multiple-sclerosis](/diseases/multiple-sclerosis), sphingolipid signaling through S1P receptors
matched in: search_vector
-
Multiple Sclerosis Gut microbiome alterations in [multiple-sclerosis](/diseases/multiple-sclerosis) include
matched in: search_vector
-
Multiple Sclerosis DAM contribute to both pathology and repair in
matched in: search_vector
-
Multiple Sclerosis Fatigue Amantadine is commonly used off-label for the treatment of fatigue in [
matched in: search_vector
-
Multiple Sclerosis — MS and dorsal column pathology ](/cell-types/nucleus-cuneatus-neurons-—-upper-limb-somatosensory-relay --somatosensory-pathway-—-ascending-sensory-pathways --primary-somatosensory-cortex-—-cortical-target --parkinson's-disease-—-pd-and-sensory-deficits --
matched in: search_vector
-
# AAN 2026 — Multiple Sclerosis **Dates:** April 18-22, 2026 **Location
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis) ([Meldrum, 2000](https://doi.org/10.1093/jn/130.4.1007S); [Dong et al., 2009](https://doi.org
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis)**: Serum GFAP peaks during acute relapses and correlates
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis), highlighting the importance of differential diagnosis in patients
matched in: search_vector
-
multiple-sclerosis, and als.[@lima2025] - A meta-analysis of 18 randomized
matched in: search_vector
-
multiple-sclerosis, niemann-pick-type-c - **Young-onset dementia**: alzheimers
matched in: search_vector
-
multiple-sclerosis | | Attention | Digit Span, Continuous Performance Test | lewy-body
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis)**: While MS is an acquired demyelinating disease
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis), making it a compelling target for neuroprotective
matched in: search_vector
-
multiple-sclerosis, traumatic-brain-injury, and cte. - **Prognostic value**: Higher
matched in: search_vector
-
multiple-sclerosis](/diseases/multiple-sclerosis) | [@cattaneo2017] | **Akkermansia muciniphila** | Mucin degradation; barrier integrity
matched in: search_vector
-
multiple-sclerosis, intervention:glucoraphanin, intervention:sulforaphane, phase:phase-1-phase
matched in: search_vector
-
parkinsons (n.d.) 15. Unknown, - als (n.d.) 16. Unknown, - multiple-sclerosis (n.d.)
matched in: search_vector
-
multiple-sclerosis. Pyroptotic cell death in the central nervous system
matched in: search_vector